Orlando, FL -- (SBWIRE) -- 09/09/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Cord Blood America Inc. (OTCBB:CBAI), Advanced Cell Technology, Inc. (OTCBB:ACTC).
Cord Blood America Inc. (OTCBB:CBAI) shares gained 5.26% and closed at $0.0020. The company on August 15 announced financial results for the quarter ended June 30, 2013. For the three months ended June 30, 2013, total revenue decreased to approximately $1.49 million from $1.70 million. Recurring revenue increased approximately 6% from the year ago period. For the three month period ending June 30, 2013 and June 30, 2012, depreciation and amortization was approximately $0.19 million. For the period ending June 30, 2013, the company had $0.61 million in cash, an increase of 56% from $0.39 million at December 31, 2012.
The company is a holding company. CBAI is primarily an umbilical cord blood stem cell preservation company, with a particular focus on the acquisition of customers in need of family based products and services. CBAI’s wholly owned subsidiaries include Cord Partners, Inc., CorCell Companies. Inc., CorCell Ltd., (Cord), CBA Professional Services, Inc. doing business as (D/B/A) BodyCells, Inc. (BodyCells), CBA Properties, Inc. (Properties), and Career Channel Inc D/B/A Rainmakers International (Rain). The Properties was formed to hold the corporate trademarks and other intellectual property.
Are investors worried about the recent updates with CBAI? Find out with a free trend analysis HERE
Advanced Cell Technology, Inc. (OTCBB:ACTC) shares dropped 2.01% to $0.0585. The company on August 12 announced that it has filed preliminary proxy materials with the Securities and Exchange Commission (SEC) in connection with its 2013 Annual Meeting of Stockholders on October 22, 2013 (the “2013 Annual Meeting”).
The proposals at the 2013 Annual Meeting include: Election of the six director nominees listed in the proxy statement; Amendment of the company’s Certificate of Incorporation to increase the authorized shares of its common stock to 3.75 billion shares, an increase of one billion shares.
Additionally, the company on August 7 announced second quarter financial results for the period ended June 30, 2013. The company had revenue totaling $58,268 for the 2013 second quarter, compared to revenue of $218,184 in the prior year. The company reported a net loss of $(6.6) million or $(0.00) loss per share in the 2013 second quarter, compared to a net loss in the same period of 2012 of $(4.0) million, or $(0.0) per share. Net cash used in operations for the 2013 second quarter was $4.2 million, compared to net cash used in operations of $2.9 million in the same period in 2012.
Is ACTC going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)